{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:02:23Z","timestamp":1780668143810,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.suronc.2026.102429","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:03:39Z","timestamp":1776985419000},"page":"102429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcomes of minimally invasive conversion surgery after immune checkpoint inhibitors for stage IV gastric cancer"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-1444","authenticated-orcid":false,"given":"En","family":"Amada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.suronc.2026.102429_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10251","key":"10.1016\/j.suronc.2026.102429_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.suronc.2026.102429_bib3","article-title":"Chemotherapy for advanced gastric cancer","author":"Wagner","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10184","key":"10.1016\/j.suronc.2026.102429_bib4","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","article-title":"Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel for resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4)","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.suronc.2026.102429_bib5","first-page":"329","article-title":"Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification","volume":"2","author":"Yoshida","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"issue":"2","key":"10.1016\/j.suronc.2026.102429_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","article-title":"The concept of conversion surgery for stage IV gastric cancer: the proposal of new biological categories of classification","volume":"19","author":"Yoshida","year":"2016","journal-title":"Gastric Cancer"},{"issue":"11","key":"10.1016\/j.suronc.2026.102429_bib7","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1245\/s10434-015-4422-6","article-title":"Prognostic role of conversion surgery for unresectable gastric cancer","volume":"22","author":"Fukuchi","year":"2015","journal-title":"Ann. Surg Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102429_bib8","first-page":"11","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649)","volume":"384","author":"Janjigian","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10242","key":"10.1016\/j.suronc.2026.102429_bib9","first-page":"401","article-title":"Efficacy and safety of nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer","volume":"395","author":"Shitara","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.suronc.2026.102429_bib10","first-page":"983","article-title":"Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer","volume":"270","author":"Kim","year":"2019","journal-title":"Ann. Surg."},{"issue":"10","key":"10.1016\/j.suronc.2026.102429_bib11","first-page":"1245","article-title":"Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT)","volume":"21","author":"Hyung","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2026.102429_bib12","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.TPS4134","article-title":"Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial)","volume":"35","author":"Tokunaga","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2026.102429_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s10120-023-01453-7","article-title":"Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704)","volume":"27","author":"Kurokawa","year":"2024","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.suronc.2026.102429_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ags3.12515","article-title":"International retrospective cohort Study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1)","volume":"6","author":"Yoshida","year":"2022","journal-title":"Ann. Gastroenterol. Surg."},{"issue":"1","key":"10.1016\/j.suronc.2026.102429_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"issue":"8","key":"10.1016\/j.suronc.2026.102429_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041883","article-title":"The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer","volume":"7","author":"Richards","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.suronc.2026.102429_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","year":"2011","journal-title":"Gastric Cancer"},{"issue":"21","key":"10.1016\/j.suronc.2026.102429_bib18","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.suronc.2026.102429_bib19","first-page":"311","article-title":"Outcomes of minimally invasive conversion surgery for unresectable advanced gastric cancer","volume":"30","author":"Yoshida","year":"2025","journal-title":"Journal of Japan Society for Endoscopic Surgery"},{"key":"10.1016\/j.suronc.2026.102429_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11206100","article-title":"Improvement of body weight and nutritional status in gastric cancer patients enhances the benefit of Nivolumab therapy","volume":"11","author":"Ikoma","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.suronc.2026.102429_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/01635581.2022.2162090","article-title":"The impact of nutritional support on survival outcomes in patients with advanced gastric adenocarcinoma treated with chemotherapy","volume":"75","author":"Sugiyama","year":"2023","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.suronc.2026.102429_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/nu13082766","article-title":"Nutritional support indications in gastroesophageal cancer patients: from perioperative to palliative systemic therapy. A comprehensive review of the last decade","volume":"13","author":"Mulazzani","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.suronc.2026.102429_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41416-020-0975-7","article-title":"Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer","volume":"123","author":"Hagi","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.suronc.2026.102429_bib24","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1245\/s10434-024-16161-4","article-title":"Conversion surgery after chemotherapy plus nivolumab as the first-line treatment for unresectable advanced or recurrent gastric cancer and a biomarker Study using the gustave roussy immune Score: a multicenter Study","volume":"31","author":"Nakazawa","year":"2024","journal-title":"Ann. Surg Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:03:46Z","timestamp":1780664626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740426000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":24,"alternative-id":["S0960740426000800"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102429","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of minimally invasive conversion surgery after immune checkpoint inhibitors for stage IV gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102429"}}